The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

start therapy
Dec 19, 2013

Do I need with thery? VL 35.000 (In september 2012 was 8000) CD4 890 and CD8 1150. HIV since sumer 2012. What therapy to starta?

Response from Dr. Young

Hello and thanks for posting.

HIV medications are recommended here in the US for all people living with HIV, irrespective of CD4 count or viral load. Elsewhere, the World Health Organization recommends treatment (even in resource limited places) if CD4 counts are below 500. So, depending on where you live, your CD4 count may or may not meet threshold to start treatment.

There are a variety of recommended first line treatments-- I'll discuss the US recommendations. All regimens involve the use of 2 NTRIs, usually tenofovir+FTC (Truvada) or abacavir+3TC (Epzicom) with a third medication. This third medication can be a NNRTI (efavirez is most widely used), protease inhibitor (boosted darunavir or atazanavir) or an integrase inhibitor (raltegravir, cobicistat/elvitegravir, or dolutegravir). Check out these tables for more information about US Guidelines.

Hope that helps, BY

is there any chance to stay alive with pml..
Aloe Vera Juice taste test!

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint